Comparison of vasodilatory properties of 14,15-EET analogs: Structural requirements for dilation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 1 53-1, 2003, Pages

  Falck, J R ^b   Krishna, U Murali ^b   Reddy, Y Krishna ^b   Kumar, P Srinagesh ^b   Reddy, K Malla ^b   Hittner, Sarah B ^a   Deeter, Christine ^a   Sharma, Kamalesh K ^b   Gauthier, Kathryn M ^a   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Arachidonic acid; Cytochrome P 450; Endothelium derived hyperpolarizing factor; Epoxyeicosatrienoic acid

Indexed keywords

14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ARACHIDONIC ACID; CARBON 14; CYTOCHROME P450; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; EPOXYICOSATRIENOIC ACID; POTASSIUM CHLORIDE; THROMBOXANE RECEPTOR STIMULATING AGENT;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CATTLE; CHEMICAL STRUCTURE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASCULAR RING; VASODILATATION;

EID: 0037232845     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00831.2001     Document Type: Article

References (52)

1. Backes BJ and Ellman JA. Carbon-carbon bond-forming methods on solid support. Utilization of Kenner's "safety-catch" linker. J Am Chem Soc 116: 11171-11172, 1994.
2. Ca. channels. Am J Physiol Heart Circ Physiol 282: H1656-H1664, 2002.
3. Campbell WB, Gebremedhin D, Pratt PF, and Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415-423, 1996.
4. Carroll MA, Schwartzman M, Capdevila J, Falck JR, and McGiff JC. Vasoactivity of arachidonic acid epoxides. Eur J Pharmacol 138: 281-283, 1987.
5. Chen JR, Falck JR, Reddy KM, Capdevila J, and Harris RC. Epoxyeicosatrienoic acids and their sulfonimide derivatives stimulate tyrosine phosphorylation and induce mitogenesis in renal epithelial cells. J Biol Chem 273: 29254-29261, 1998.
6. Cohen RA and Vanhoutte PM. Endothelium-dependent byperpolarization: Beyond nitric oxide and cyclic GMP. Circulation 92:3337-3349, 1995.
7. Corey EJ, Niwa H, and Falck JR. Selective epoxidation of eicosa-cis-5,8,11,14-tetraenoic (arachidonic) acid and eicosa-cis-8,11,14-trienoic acid. J Am Chem Soc 101: 586-587, 1979.
8. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396: 269-272, 1998.
9. Ellis EF, Police RJ, Yancy L, McKinney JS, and Amruthesh SC. Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am J Physiol Heart Circ Physiol 259: H1171-H1177, 1990.
10. Falck JR, Kumar PS, Reddy YK, Zou G, and Capdevila JH. Stereospecific synthesis of EET metabolites via Suzuki-Miyaura coupling. Tetrahedron Lett 42: 7211-7212, 2001.
11. Falck JR, Manna S, Viala J, and Siddhanta AK. Arachidonate epoxygenase: Inhibitors and metabolite analogues. Tetrahedron Lett 26: 2287-2290, 1985.
12. Falck JR, Yadagiri P, and Capdevila J. Synthesis of epoxyeicosatrienoic acids and heteroatom analogs. Methods Enzymol 187:357-364, 1990.
13. Fang X, Kaduce TL, VanRollins M, Weintraub NL, and Spector AA. Conversion of epoxyeicosatrienoic acids (EETs) to chain-shortened epoxy fatty acids by human skin fibroblasts. J Lipid Res 41: 66-74, 2000.
14. Fang X, Kaduce TL, Weintraub NL, VanRollins M, and Spector AA. Functional implications of a newly characterized pathway of 11,12-epoxyeicosatrienoic acid metabolism in arterial smooth muscle. Circ Res 79: 784-793, 1996.
15. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, and Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401: 493-497, 1999.
16. Ca channels expressed in human embryonic kidney 293 cells by epoxyeicosatrienoic acid. Mol Pharmacol 59: 16-23, 2001.
17. Fulton D, Falck JR, McGiff JC, Carroll MA, and Quilley J. A method for the determination of 5,6-EET using the lactone as an intermediate in the formation of the diol. J Lipid Res 39: 1713-1721, 1998.
18. Fulton D, Mahboubi K, McGiff JC, and Quilley J. Cytochrome P450-dependent effects of bradykinin in the rat heart. Br J Pharmacol 114: 99-102, 1995.
19. Furchgott RF and Zawadzki JW. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
20. Gauthier KM, Deeter C, Krishna UM, Reddy YK, Bondlela M, Falck JR, and Campbell WB. 14,15-Epoxyeicosa-5(Z)-enoic acid: A selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ Res 90: 1028-1036, 2002.
21. + channels in porcine coronary artery smooth muscle cells. J Cardiovasc Pharmacol 32: 642-649, 1998.
22. 3SnH-catalyzed reductive cyclization of enals and enones. Tetrahedron 55: 8815-8832, 1999.
23. Hecker M, Bara AT, Bauersachs J, and Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol 481: 407-414, 1994.
24. Krishna UM, Reddy MM, Xia J, Falck JR, and Balazy M. Stereospecific synthesis of trans-arachidonic acids. Bioorg Med Chem Lett 11: 2415-2418, 2001.
25. Kuhl WE and Spector AA. Uptake of long-chain fatty acid-methyl esters by mammalian cells. J Lipid Res 11: 458-465, 1970.
26. Leffler CW and Fedinec AL. Newborn piglet cerebral microvascular responses to epoxyeicosatrienoic acids. Am J Physiol Heart Circ Physiol 273: H333-H338, 1997.
27. Li PL and Campbell WB. Epoxyeicosatrienoic acids activate potassium channels in coronary smooth muscle through guanine nucleotide binding protein. Circ Res 80: 877-884, 1997.
28. Li PL, Chen CL, Bortell R, and Campbell WB. 11,12-Epoxyeicosatrienoic acid stimulates endogenous mono-ADP-ribosylation in bovine coronary arterial smooth muscle. Circ Res 85: 349-356, 1999.
29. Lipshutz BH, Kim SK, Mollard P, Blomgren PA, and Stevens KL. Nickel(0)-catalyzed couplings of vinyl-alanes and -zirconocenes with chloromethylated heteroaromatics: A route to E-allylated heterocycles. Tetrahedron 54: 6999-7012, 1998.
30. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kandaide H, and Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 106: 1521-1530, 2000.
31. 2 and prostacyclin. Pharmacol Rev 30: 293-331, 1979.
32. Nithipatikom K, Pratt PF, and Campbell WB. Determination of EETs using microbore liquid chromatography with fluorescence detection. Am J Physiol Heart Circ Physiol 279: H857-H862, 2000.
33. Oltman CL, Weintraub NL, VanRollins M, and Dellsperger KC. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Circ Res 83: 932-939, 1998.
34. Pfister SL, Spitzbarth N, Nithipatikom K, Edgemond WS, Falck JR, and Campbell WB. Identification of 11,14,15- and 11,12,15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta. J Biol Chem 273: 30879-30887, 1998.
35. Pratt PF, Li P, Hillard CJ, Kurian J, and Campbell WB. Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs. Am J Physiol Heart Circ Physiol 280: H1113-H1121, 2001.
36. Proctor KG, Falck JR, and Capdevila J. Intestinal vasodilation by epoxyeicosatrienoic acids: Arachidonic acid metabolites produced by a cytochrome P450 monooxygenase. Circ Res 60: 50-59, 1987.
37. Randall MD, Alexander SPH, Bennett T, Boyd EA, Fry JR, Gardiner SM, Kemp PA, McCulloch AI, and Kendall DA. An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun 229: 114-120, 1996.
38. Rao AVR and Reddy GR. First total synthesis of niphatesines A-D and assignment of absolute configuration. Tetrahedron Lett 34:8329-8332, 1993.
39. 2 and EETs in the relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol Heart Circ Physiol 264: H327-H335, 1993.
40. Rosolowsky M and Campbell WB. Synthesis of hydroxy-eicosatetraenoic acids (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells. Biochim Biophys Acta 1299: 267-277, 1996.
41. Rosolowsky M, Falck JR, Willerson JT, and Campbell WB. Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries. Circ Res 66: 608-621, 1990.
42. Spector AA and Soboroff JM. Long chain fatty acid methyl ester hydrolase activity in mammalian cells. Lipids 7: 186-190, 1972.
43. 2t-isoprostane, a human hormone? J Am Chem Soc 121: 7773-7777, 1999.
44. VanRollins M, Kaduce TL, Knapp HR, and Spector AA. 14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells. J Lipid Res 34: 1931-1942, 1993.
45. Weintraub NL, Fang X, Kaduce TL, VanRollins M, Chatterjee P, and Spector AA. Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids. Circ Res 81: 258-267, 1997.
46. Weintraub NL, Fang X, Kaduce TL, VanRollins M, Chatterjee P, and Spector AA. Epoxide hydrolase regulates epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids. Am J Physiol Heart Circ Physiol 277: H2098-H2108, 1999.
47. Wong PYK, Lai PS, and Falck JR. Mechanism and signal transduction of 14(R), 15 (S)-epoxyeicosatrienoic acid (14,15-EET) binding in guinea pig monocytes. Prostaglandins Other Lipid Mediat 62: 321-333, 2000.
48. Wong PYK, Lai PS, Shen SY, Belosludtsev YY, and Falck JR. Post-receptor signal transduction and regulation of 14(R), 15(S)-epoxyeicosatrienoic acid (14,15-EET) binding in U-937 cells. J Lipid Mediat Cell Signal 16: 155-169, 1977.
49. Yadav JS, Shekharam T, and Gadgil VR. Titanocene induced regioselective deoxygenation of 2,3-epoxy alcohols: A new reaction for the synthesis of allylic alcohols. J Chem Soc Chem Commun 11: 843-844, 1990.
50. Zeldin DC, Kobayashi J, Falck JR, Winder BS, Hammock BD, Snapper JR, and Capdevila JH. Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J Biol Chem 268: 6402-6407, 1993.
51. Zeldin DC, Shouzou W, Falck JR, Hammock BD, Snapper JR, and Capdevila JH. Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: Substrate structural determinants of asymmetric catalysis. Arch Biochem Biophys 316: 443-451, 1995.
52. + channel activity. Am J Physiol Renal Fluid Electrolyte Physiol 270: F822-F832, 1996.